Levi & Korsinsky law firm has announced a class action lawsuit against Neumora Therapeutics (NMRA) regarding potential misrepresentations in their clinical trial data for Navacaprant, their therapeutic candidate for Major Depressive Disorder (MDD). The lawsuit alleges that the company manipulated trial inclusion criteria and statistical analysis to show favorable results, potentially misleading investors about the drug's efficacy.